3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Infections
3
Prostatic Neoplasms
2
Pancreatic Cyst
2
Breast Neoplasms
2
Urinary Tract Infections
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Staphylococcal Infections
1
Squamous Cell Carcinoma of Head and Neck
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Pneumonia
1
Pain
1
Neutropenia
1
Neoplasms
1
Multiple Myeloma
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Leukemia, B-Cell
1
Intraabdominal Infections
1
Influenza, Human
1
Inflammation
1
Interventions
pegylated granulocyte colony-stimulating factor
3
pegfilgrastim
3
Vancomycin
3
Interleukin 1 Receptor Antagonist Protein
2
Filgrastim
2
Ceftazidime
2
Cefepime
2
Amikacin
2
Vaccination
1
Teicoplanin
1
Tazobactam
1
Surveys and Questionnaires
1
Sodium Chloride
1
Positron Emission Tomography Computed Tomography
1
Pneumococcal Vaccines
1
Piperacillin
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Meropenem
1
Linezolid
1
Itraconazole
1
Injections
1
Cloxacillin
1
Ciprofloxacin
1
Cilastatin, Imipenem Drug Combination
1
Bevacizumab
1
Anti-Bacterial Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Febrile Neutropenia
×
Ciprofloxacin
×
Clear all
NCT04948463
2026-03-20
ELSA-FN
Murdoch Childrens Research Institute
Phase 4
Completed
55 enrolled